Synthetic lipid nanoparticles targeting steroid organs
Lipidots are original nanoparticulate lipid delivery vectors for drugs and contrast agents
made from materials generally regarded as safe. Here, we characterized the in vivo stability …
made from materials generally regarded as safe. Here, we characterized the in vivo stability …
99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution
S Ballot, N Noiret, F Hindré, B Denizot, E Garin… - European journal of …, 2006 - Springer
Purpose This study focusses on a promising carrier system for imaging and therapeutic
purposes using lipid nanocapsules. To assess their potential for clinical use, we labelled …
purposes using lipid nanocapsules. To assess their potential for clinical use, we labelled …
Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals
A Helbok, C Decristoforo, G Dobrozemsky… - Journal of liposome …, 2010 - Taylor & Francis
Radiolabeling of nanoparticles (NPs) has been performed for a variety of reasons, such as
for studying pharmacokinetics, for imaging, or for therapy. Here, we describe the in vitro and …
for studying pharmacokinetics, for imaging, or for therapy. Here, we describe the in vitro and …
A correlative imaging study of in vivo and ex vivo biodistribution of solid lipid nanoparticles
S Mannucci, F Boschi, B Cisterna… - International Journal …, 2020 - Taylor & Francis
Purpose Solid lipid nanoparticles are largely used in biomedical research and are
characterized by high stability and biocompatibility and are also able to improve the stability …
characterized by high stability and biocompatibility and are also able to improve the stability …
[HTML][HTML] Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications
YQ Zhao, LJ Li, EF Zhou, JY Wang, Y Wang… - Pharmaceutical …, 2022 - thieme-connect.com
Lipid-based nanocarriers have been extensively investigated for drug delivery due to their
advantages including biodegradability, biocompatibility, nontoxicity, and …
advantages including biodegradability, biocompatibility, nontoxicity, and …
Biodistribution of nanostructured lipid carriers (NLCs) after intravenous administration to rats: influence of technological factors
Nanoparticles for medical applications are frequently administered via parenteral
administration. In this study, the tissue distribution of three lipid formulations based on …
administration. In this study, the tissue distribution of three lipid formulations based on …
Radiolabeled liposomes and lipoproteins as lipidic nanoparticles for imaging and therapy
L Aranda-Lara, E Morales-Avila… - Chemistry and Physics …, 2020 - Elsevier
Radiolabeled lipidic nanoparticles, particularly liposomes and lipoproteins, are of great
interest as agents for imaging and therapy, due not only to their peculiar physicochemical …
interest as agents for imaging and therapy, due not only to their peculiar physicochemical …
Perspectives on cutting‐edge nanoparticulate drug delivery technologies based on lipids and their applications
B Maddiboyina, Ramaiah… - Chemical Biology & …, 2023 - Wiley Online Library
Numerous nanotech arenas in therapeutic biology have recently provided a scientific
platform to manufacture a considerable swath of unique chemical entities focusing on drugs …
platform to manufacture a considerable swath of unique chemical entities focusing on drugs …
Biodistribution of dual radiolabeled lipidic nanocapsules in the rat using scintigraphy and γ counting
A Cahouet, B Denizot, F Hindre, C Passirani… - International journal of …, 2002 - Elsevier
The aim of the present work was to study the biodistribution of a radiolabeled lipidic
nanocapsule formulation after intravenous administration in rat by scintigraphy and γ …
nanocapsule formulation after intravenous administration in rat by scintigraphy and γ …
Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution
The aim of this study was to develop a nanostructured lipid carriers (NLC) formulation
containing spironolactone (SPN-NLCs), and to investigate its potential for the oral delivery of …
containing spironolactone (SPN-NLCs), and to investigate its potential for the oral delivery of …